Seeing Is Believing
Currently out of the existing stock ratings of Matthew Taylor, 128 are a BUY (60.95%), 64 are a HOLD (30.48%), 18 are a SELL (8.57%).
Analyst Matthew Taylor, currently employed at JEFFERIES, carries an average stock price target met ratio of 68.55% that have a potential upside of 18.02% achieved within 163 days.
Matthew Taylor’s has documented 388 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PHG, Koninklijke Philips NV ADR at 29-Oct-2024.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$130
$11.4 (9.61%)
$105
19 days ago
(17-Oct-2024)
4/5 (80%)
$12.11 (10.27%)
124
Buy
$146
$27.4 (23.10%)
$136
19 days ago
(17-Oct-2024)
8/12 (66.67%)
$28.11 (23.84%)
256
Hold
$125
$6.4 (5.40%)
$112
19 days ago
(17-Oct-2024)
10/12 (83.33%)
$7.11 (6.03%)
308
Buy
$138
$19.4 (16.36%)
$133
19 days ago
(17-Oct-2024)
1/4 (25%)
$20.11 (17.06%)
344
Buy
$129
$10.4 (8.77%)
$127
22 days ago
(14-Oct-2024)
12/20 (60%)
$11.75 (10.02%)
193
Which stock is Matthew Taylor is most bullish on?
Which stock is Matthew Taylor is most reserved on?
What Year was the first public recommendation made by Matthew Taylor?